Literature DB >> 15116309

Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals.

Anthony Kebba1, Pontiano Kaleebu, Samantha Rowland, Rebecca Ingram, Jimmy Whitworth, Nesrina Imami, Frances Gotch.   

Abstract

It is unclear how human immunodeficiency virus (HIV) type 1-specific immune responses in exposed seronegative (ESN) individuals differ from those in HIV-1-infected subjects. By use of overlapping peptides spanning Gag, Tat, Nef, Vif, Vpr, and Vpu, peripheral blood mononuclear cells from ESN individuals, their seropositive (SP) partners, and unexposed seronegative control subjects were screened for interferon- gamma production. Responses were more frequent (95.7% vs. 20%), of a higher magnitude (9-fold), and of wider breadth (median number of peptides recognized, 18 vs. 2.5) in SP than in ESN individuals. Peptides recognized by ESN individuals were less frequently recognized by their SP partners. SP subjects infrequently recognized peptides from Vif, and such responses were subdominant; among ESN individuals, this HIV-1 protein was most frequently recognized. Immunodominant peptides recognized by SP subjects tended to be from relatively conserved regions, whereas peptides recognized by ESN individuals were associated with slow disease progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15116309     DOI: 10.1086/383227

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.

Authors:  A L Erickson; C B Willberg; V McMahan; A Liu; S P Buchbinder; L A Grohskopf; R M Grant; D F Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

2.  Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.

Authors:  Peter J Kuebler; Megha L Mehrotra; J Jeff McConnell; Sara J Holditch; Brian I Shaw; Leandro F Tarosso; Kaitlyn S Leadabrand; Jeffrey M Milush; Vanessa A York; Rui André Saraiva Raposo; Rex G Cheng; Emily M Eriksson; Vanessa McMahan; David V Glidden; Stephen Shiboski; Robert M Grant; Douglas F Nixon; Esper G Kallás
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

3.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

4.  Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya.

Authors:  A Y Liu; B Lohman-Payne; M H Chung; J Kiarie; J Kinuthia; J Slyker; B Richardson; D Lehman; C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2015-04-20       Impact factor: 4.330

5.  CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.

Authors:  Shameem Z Jaumdally; Anabela Picton; Caroline T Tiemessen; Maria Paximadis; Heather B Jaspan; Hoyam Gamieldien; Lindi Masson; David Coetzee; Anna-Lise Williamson; Francesca Little; Pamela P Gumbi; Jo-Ann S Passmore
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

6.  Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.

Authors:  Emily C Speelmon; Devon Livingston-Rosanoff; Anthony L Desbien; Jean Lee; W David Wick; Florian Hladik; M Juliana McElrath
Journal:  AIDS Res Hum Retroviruses       Date:  2008-11       Impact factor: 2.205

7.  CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Authors:  Jennifer Serwanga; Susan Mugaba; Auma Betty; Edward Pimego; Sarah Walker; Paula Munderi; Charles Gilks; Frances Gotch; Heiner Grosskurth; Pontiano Kaleebu
Journal:  AIDS Res Treat       Date:  2011-01-18

8.  Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.

Authors:  Evélyne Bégaud; Loïc Chartier; Valéry Marechal; Julienne Ipero; Josianne Léal; Pierre Versmisse; Guillaume Breton; Arnaud Fontanet; Corinne Capoulade-Metay; Hervé Fleury; Françoise Barré-Sinoussi; Daniel Scott-Algara; Gianfranco Pancino
Journal:  Retrovirology       Date:  2006-06-22       Impact factor: 4.602

Review 9.  Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.

Authors:  Sandra Milena Gonzalez; Natalia Andrea Taborda; María Teresa Rugeles
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

10.  Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

Authors:  Anna A Herasimtschuk; Samantha J Westrop; Graeme J Moyle; Jocelyn S Downey; Nesrina Imami
Journal:  J Immune Based Ther Vaccines       Date:  2008-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.